News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Novartis Opens New Radioligand Therapy Manufacturing Plant in California as Part of $23 Billion US Expansion Plan
Tuesday, November 11, 2025Novartis a global leader in innovative medicines has opened a new squarefoot radioligand therapy RLT manufacturing plant in Carlsbad California The facility marks a major step in the companys billion investment
KalVista Pharmaceuticals Initiates First European Launch of EKTERLY® for Hereditary Angioedema in Germany Following EU Approval
Tuesday, November 11, 2025KalVista Pharmaceuticals has begun distribution of EKTERLY the first oral ondemand hereditary angioedema therapy in Germany following recent European regulatory approval
European Union Launches Ambitious Life Science Strategy to Bolster Innovation and Global Competitiveness by 2030
Monday, November 10, 2025The European Commission today launched a transformative life science strategy to strengthen EU innovation market access and competitiveness by
Cue Biopharma and ImmunoScape form strategic partnership to develop new cell therapy for solid tumours
Friday, November 07, 2025Cue Biopharma Inc a clinicalstage biopharmaceutical company focused on developing targeted Tcell therapies for autoimmune diseases and cancer has entered into a collaboration and licence agreement with ImmunoScape Pte
Urteste S.A. launches European multicenter clinical study of the Panuri test
Friday, November 07, 2025Urteste SA begins a multicenter clinical trial in Europe for its noninvasive Panuri test to detect pancreatic cancer collaborating with Aurevia in Poland Hungary and Italy
Jupiter Neurosciences Receives U.S. FDA Clearance to Begin Phase 2a Trial of JOTROL™ for Parkinson’s Disease
Thursday, November 06, 2025Jupiter Neurosciences Inc a clinicalstage pharmaceutical company developing JOTROL a patented resveratrolbased therapeutic platform targeting neuroinflammation and mitochondrial dysfunction
Pharming Group Reports Strong Q3 2025 Revenue Growth, Strategic Refocus and Pipeline Advances in Rare Disease Segment
Thursday, November 06, 2025Pharming Group reported significant revenue and profitability growth in Q announced a strategic withdrawal from nonUS RUCONEST markets pipeline progress for leniolisib and key leadership changes to bolster its global rare disease focus
Boehringer Ingelheim and CDR-Life Sign Global Licensing Agreement for CDR111, a Trispecific Antibody for Autoimmune Diseases
Wednesday, November 05, 2025Boehringer Ingelheim and CDRLife Inc have entered into a global licensing agreement to develop CDR a trispecific antibodybased molecule designed for the treatment of autoimmune diseases
Moberg Pharma and Karo Healthcare Forge Exclusive License to Launch MOB-015 (Terclara®) Across 19 European Markets
Wednesday, November 05, 2025Moberg Pharma and Karo Healthcare have signed an exclusive agreement to commercialize MOB Terclara across key European markets under the Lamisil brand establishing a new frontrunner in the antifungal therapeutics arena
Eli Lilly Unveils $3 Billion Manufacturing Facility in Netherlands, Marking Major Investment in European Pharma Supply Chain
Tuesday, November 04, 2025Eli Lilly announces a billion investment in a new oral medicines manufacturing facility at Leiden Bio Science Park Netherlands enhancing its European production and supply chain capabilities
